KTC-1 Cells

The KTC-1 cell line is a well-characterized human thyroid carcinoma cell model derived from an adult patient with poorly differentiated thyroid carcinoma. This cell line is particularly valuable in research focused on the aggressive forms of thyroid cancer, including anaplastic thyroid carcinoma (ATC), due to its origins from a cancer type that is known for rapid progression and resistance to conventional therapies. The KTC-1 cells exhibit a spindle-shaped morphology, consistent with epithelial-to-mesenchymal transition (EMT), which is a hallmark of highly invasive cancers. These cells are known to have mutations in key oncogenes and tumor suppressor genes, including BRAF and TP53, which contribute to their malignant phenotype. KTC-1 cells are a useful model for studying the molecular mechanisms underlying thyroid cancer progression, including signaling pathways such as MAPK/ERK and PI3K/AKT, which are often dysregulated in aggressive thyroid cancers. They are also employed in drug screening assays to evaluate the efficacy of novel therapeutic agents targeting these pathways. Additionally, KTC-1 cells have been utilized in research exploring the tumor microenvironment, particularly the interactions between cancer cells and stromal cells that may influence tumor growth and metastasis. Due to their well-documented genetic and phenotypic characteristics, KTC-1 cells provide a robust platform for translational research aimed at developing more effective treatment strategies for aggressive thyroid carcinomas.